Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
Assessment of the WATCHMAN Device in Patients Unsuitable for Oral Anticoagulation
Principal Investigator (?)
Study Number
F18061
Summary
The purpose of this study is to establish the safety and effectiveness of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device, including the post-implant medication regimen, for subjects with non-valvular atrial fibrillation who are deemed not to be eligible for anti-coagulation therapy to reduce the risk of stroke. 
Phase (?)
Phase III
Sponsor (?)
Contact

Hannah Ellis

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0